The European Union announced a COVID-19 vaccine strategy yesterday to deliver a vaccine within 12 to 18 months, or possibly sooner, and to procure an adequate supply for EU members. Read More

Sponsors of trials impacted by the COVID-19 pandemic have several statistical analysis options for mitigating the effect of missing data, according to the FDA. Read More

Chinese government-owned vaccine developer Sinopharma says its COVID-19 vaccine candidate has generated a 100 percent antibody response in patients who were given two medium doses 28 days apart. Read More

CureVac has won approval in Germany and Belgium for a phase 1 trial of its COVID-19 vaccine, just days after the German government announced it was acquiring a 23 percent stake in the company. Read More

Regulators, drugmakers and researchers need to work in parallel to speed development of COVID-19 vaccines and treatments and prepare for the hurdles still to come, a former FDA commissioner advised. Read More

Patients taking hydroxychloroquine and chloroquine to treat other health conditions can continue to do so, the agency said. Read More

Trump administration officials announced yesterday that 300 million doses of a COVID-19 vaccine should be available by January 2021 under Operation Warp Speed although they stressed there’s no guarantee that a vaccine will be available by then. Read More

The University of Oxford’s RECOVERY trial has found that a cheap and widely available steroid provides a benefit in COVID-19 patients and should become standard of care in patients sick enough to require oxygen. Read More